ATE305000T1 - Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind - Google Patents

Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind

Info

Publication number
ATE305000T1
ATE305000T1 AT97946641T AT97946641T ATE305000T1 AT E305000 T1 ATE305000 T1 AT E305000T1 AT 97946641 T AT97946641 T AT 97946641T AT 97946641 T AT97946641 T AT 97946641T AT E305000 T1 ATE305000 T1 AT E305000T1
Authority
AT
Austria
Prior art keywords
indolylquinones
mono
bis
sysnthesic
producing
Prior art date
Application number
AT97946641T
Other languages
English (en)
Inventor
Peng C Tang
G David Harris
Original Assignee
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc filed Critical Sugen Inc
Application granted granted Critical
Publication of ATE305000T1 publication Critical patent/ATE305000T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT97946641T 1996-11-13 1997-11-12 Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind ATE305000T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3060496P 1996-11-13 1996-11-13
US4298997P 1997-04-14 1997-04-14
US08/964,791 US5786488A (en) 1996-11-13 1997-11-05 Synthetic methods for the preparation of indolyquinones
PCT/US1997/020557 WO1998020874A1 (en) 1996-11-13 1997-11-12 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom

Publications (1)

Publication Number Publication Date
ATE305000T1 true ATE305000T1 (de) 2005-10-15

Family

ID=27363680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946641T ATE305000T1 (de) 1996-11-13 1997-11-12 Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind

Country Status (9)

Country Link
US (3) US5786488A (de)
EP (1) EP0959881B1 (de)
JP (1) JP2001504820A (de)
AT (1) ATE305000T1 (de)
AU (1) AU5177098A (de)
CA (1) CA2271737A1 (de)
DE (1) DE69734246T2 (de)
ES (1) ES2251035T3 (de)
WO (1) WO1998020874A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376529B1 (en) * 1995-06-07 2002-04-23 Peng Cho Tang Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
US6147106A (en) * 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5786488A (en) * 1996-11-13 1998-07-28 Sugen, Inc. Synthetic methods for the preparation of indolyquinones
US6316429B1 (en) * 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
US6486185B1 (en) 1997-05-07 2002-11-26 Sugen, Inc. 3-heteroarylidene-2-indolinone protein kinase inhibitors
US6051597A (en) * 1997-06-13 2000-04-18 Merck & Co., Inc. Indolylquinones as antidiabetic agents
US6114371A (en) * 1997-06-20 2000-09-05 Sugen, Inc. 3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors
AU748432B2 (en) * 1998-04-02 2002-06-06 Merck & Co., Inc. Antidiabetic agents
HUP0102932A3 (en) * 1998-05-22 2002-12-28 Shionogi Biores Corp Lexington Bioreductive cytotoxic agents
IL139934A (en) 1998-05-29 2007-10-31 Sugen Inc History 2 - Indulinone converted to pyrrole and pharmaceutical preparations containing them
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
DE122008000002I1 (de) * 2000-02-15 2008-04-17 Sugen Inc Pyrrol substituierte indolin-2-on protein kinase inhibitoren
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP1434774A1 (de) 2001-10-10 2004-07-07 Sugen, Inc. 3-(4-substituierte heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivate als protein-kinase-inhibitoren
US7057052B2 (en) * 2002-09-26 2006-06-06 Duke University Heterocyclic quinones as pharmaceutical agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917820A (en) * 1969-05-29 1975-11-04 Canadian Patents Dev Antibiotic cochliodinol and production by chaetomium, cochliodes and chaetomium globsum
EP0095239B1 (de) * 1982-04-30 1986-07-09 Imperial Chemical Industries Plc Delignifizierung von Lignocellulosematerial
JPS6360966A (ja) * 1986-08-29 1988-03-17 Kyoto Yakuhin Kogyo Kk キノン誘導体
EP0817967A4 (de) 1995-03-31 2000-05-17 Merck & Co Inc Test für insulin nachahmende und verstärkende substanzen
US5786488A (en) * 1996-11-13 1998-07-28 Sugen, Inc. Synthetic methods for the preparation of indolyquinones
WO1996040115A1 (en) * 1995-06-07 1996-12-19 Sugen, Inc. Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
US6376529B1 (en) * 1995-06-07 2002-04-23 Peng Cho Tang Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
US6051597A (en) * 1997-06-13 2000-04-18 Merck & Co., Inc. Indolylquinones as antidiabetic agents
AU748432B2 (en) 1998-04-02 2002-06-06 Merck & Co., Inc. Antidiabetic agents
US20030073837A1 (en) * 1998-12-31 2003-04-17 Langecker Peter J. 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy

Also Published As

Publication number Publication date
EP0959881A1 (de) 1999-12-01
US5786488A (en) 1998-07-28
ES2251035T3 (es) 2006-04-16
EP0959881B1 (de) 2005-09-21
DE69734246T2 (de) 2006-06-22
AU5177098A (en) 1998-06-03
US6750240B2 (en) 2004-06-15
JP2001504820A (ja) 2001-04-10
US20030060635A1 (en) 2003-03-27
US6110957A (en) 2000-08-29
DE69734246D1 (de) 2006-02-02
EP0959881A4 (de) 2001-06-27
WO1998020874A1 (en) 1998-05-22
CA2271737A1 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
ATE305000T1 (de) Sysntheseverfahren zur herstellung von indolylquinonen und mono- und bis-indolylquinone, die durch das verfahren hergestellt sind
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
ATE194142T1 (de) Verfahren zur herstellung von nukleotiden
DE69920676D1 (de) Verfahren zur Herstellung von Amin-Umsetzungsprodukt-Teilchen
DE59704288D1 (de) Verfahren zur Herstellung von Alpha,Omega-C4- bis C20-Alkenolen
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
ATE178903T1 (de) Sulfamat-derivate von 1,3,5(10)-estratrien- derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATA278988A (de) Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
ATE131474T1 (de) Verfahren zur herstellung cyclischer carbonate
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
DE69910113D1 (de) Verfahren zur Herstellung von Stickstofftrifluorid durch Gas-Feststoffreaktion
DE69704553D1 (de) Verfahren zur herstellung und isolierung von atracurium besylate
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
DE69023532D1 (de) Verfahren zur Synthese von Acylamino-Organosilicium-Verbindungen.
DE69011719D1 (de) Verfahren zur Synthese von Acylamino-organosilicium-Verbindungen.
DE59307795D1 (de) Verfahren zur herstellung von rückstandsfreiem 2,4/2,6-diaminotoluolgemisch
ATE236895T1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
ATE213734T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
DE50110561D1 (de) Non-metallocene, verfahren zur herstellung von diesen und deren verwendung zur polymerisation von olefinen
ATE147749T1 (de) Verfahren zur herstellung von azt(3'-azido-3'- desoxythymidin) und diebezüglichen verbindungen
HUT47091A (en) Process for producing tetrahydrobenzthiazols
DE69006888D1 (de) Verfahren zur Synthese von Acylamino-Organosilicon-Verbindungen.
PT77825B (de) Neue 2-azabicyclo<2.2.1>heptan-derivate verfahren zu ihrer herstellung diese enthaltende mittel und deren verwendung sowie 2-azabicyclo/2.2.1/heptan-derivate als zwischenprodukte und verfahren zu deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties